摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(5-tert-Butyl-2-methoxy-3-{3-[4-(2-methylaminomethyl-pyridin-4-yloxy)-naphthalen-1-yl]-ureido }-phenylamino)-thiazole-4-carboxylic acid ethyl ester | 476011-01-5

中文名称
——
中文别名
——
英文名称
2-(5-tert-Butyl-2-methoxy-3-{3-[4-(2-methylaminomethyl-pyridin-4-yloxy)-naphthalen-1-yl]-ureido }-phenylamino)-thiazole-4-carboxylic acid ethyl ester
英文别名
Ethyl 2-[5-tert-butyl-2-methoxy-3-[[4-[2-(methylaminomethyl)pyridin-4-yl]oxynaphthalen-1-yl]carbamoylamino]anilino]-1,3-thiazole-4-carboxylate
2-(5-tert-Butyl-2-methoxy-3-{3-[4-(2-methylaminomethyl-pyridin-4-yloxy)-naphthalen-1-yl]-ureido }-phenylamino)-thiazole-4-carboxylic acid ethyl ester化学式
CAS
476011-01-5
化学式
C35H38N6O5S
mdl
——
分子量
654.79
InChiKey
WMSUKUNIONQLIB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.7
  • 重原子数:
    47
  • 可旋转键数:
    13
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.26
  • 拓扑面积:
    164
  • 氢给体数:
    4
  • 氢受体数:
    10

文献信息

  • Compounds useful as anti-inflammatory agents
    申请人:Boehringer Ingelheim Pharmaceuticals, Inc.
    公开号:US20030008868A1
    公开(公告)日:2003-01-09
    Disclosed are compounds useful in pharmaceutic compositions for treating diseases or pathological conditions involving inflammation such as chronic inflammatory diseases. Also disclosed are processes of making such compounds.
    公开了一些化合物,可用于制备用于治疗涉及炎症的疾病或病理状况,如慢性炎症性疾病的药物组合物。还公开了制备这些化合物的方法。
  • DIARYLUREA DERIVATIVES USEFUL AS ANTI-INFLAMMATORY AGENTS
    申请人:BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
    公开号:EP1392661A1
    公开(公告)日:2004-03-03
  • US6852717B2
    申请人:——
    公开号:US6852717B2
    公开(公告)日:2005-02-08
  • [EN] DIARYLUREA DERIVATIVES USEFUL AS ANTI-INFLAMMATORY AGENTS<br/>[FR] DERIVES DE DIARYLUREE UTILISABLES EN TANT QU'AGENTS ANTI-INFLAMMATOIRES
    申请人:BOEHRINGER INGELHEIM PHARMA
    公开号:WO2002092576A1
    公开(公告)日:2002-11-21
    Disclosed are diarylurea derivatives useful in pharmaceutic compositions for treating diseases or pathological conditions involving inflammation such as chronic inflammatory diseases. Also disclosed are processes of making such compounds.
查看更多